Kintara Therapeutics, Inc. (KTRA)
USD 0.22
(-6.31%)
USD 0.22
(-6.31%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 55 Thousand | 60 Thousand | 60 Thousand | 32 Thousand | 10 Thousand | 16.34 Thousand |
| Gross Profit | -55 Thousand | -60 Thousand | -60 Thousand | -32 Thousand | -10 Thousand | -16.34 Thousand |
| Operating Expenses | 8.45 Million | 14.79 Million | 22.68 Million | 21.57 Million | 8.14 Million | 8.39 Million |
| Selling, General and Administrative Expenses | 5.78 Million | 5.48 Million | 7.5 Million | 9.75 Million | 4.51 Million | 4.73 Million |
| Research and Development Expenses | 2.66 Million | 9.31 Million | 15.17 Million | 11.81 Million | 3.63 Million | 3.66 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 8.45 Million | 14.79 Million | 22.68 Million | 21.57 Million | 8.14 Million | 8.39 Million |
| Operating Income | -8.5 Million | -14.8 Million | -22.68 Million | -21.66 Million | -7.08 Million | -8.68 Million |
| Interest Expense | - | - | 14 Thousand | 26 Thousand | - | - |
| Income Tax Expense | 76 Thousand | -147 Thousand | -42 Thousand | 26 Thousand | 981.37 Thousand | -639.84 Thousand |
| Earnings before Tax | -8.5 Million | -14.64 Million | -22.66 Million | -38.29 Million | -9.12 Million | -8.04 Million |
| Net Income | -8.5 Million | -14.64 Million | -22.61 Million | -38.32 Million | -10.1 Million | -7.4 Million |
| Earnings Per Share Basic | -3.23 | -9.04 | -23.22 | -74.02 | -48.39 | -143.87 |
| Earnings Per Share Diluted | -3.23 | -8.62 | -23.22 | -74.02 | -48.39 | -143.87 |
| Weighted Average Shares Outstanding | 2.63 Million | 1.62 Million | 974 Thousand | 517.72 Thousand | 208.88 Thousand | 51.49 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.63 Million | 1.69 Million | 974 Thousand | 517.72 Thousand | 208.88 Thousand | 51.49 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.39 Million | -14.73 Million | -22.62 Million | -38.14 Million | -9.11 Million | -8.03 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 76 Thousand | - | - | - | - | - |
| Cost of Revenue | 38 Thousand | 8000.00 | 15 Thousand | 15 Thousand | 15 Thousand | 60 Thousand |
| Gross Profit | 38 Thousand | -8000.00 | -15 Thousand | -15 Thousand | -15 Thousand | -60 Thousand |
| Operating Expenses | 2.4 Million | 2.07 Million | 1 Million | 2.96 Million | 3.34 Million | 14.79 Million |
| Selling, General and Administrative Expenses | 2.3 Million | 1.48 Million | 893 Thousand | 1.1 Million | 1.27 Million | - |
| Research and Development Expenses | 101 Thousand | 592 Thousand | 111 Thousand | 1.85 Million | 2.07 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.44 Million | 2.08 Million | 1.01 Million | 2.96 Million | 3.34 Million | 14.79 Million |
| Operating Income | 6.24 Million | -2.08 Million | -1.01 Million | -3.13 Million | -3.34 Million | -14.8 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 28.27 Thousand | -1.00 | -1.00 | -28.27 Thousand | -28.81 Thousand | -147 Thousand |
| Earnings before Tax | -2.5 Million | -2.01 Million | -1.02 Million | -2.96 Million | -3.33 Million | -14.64 Million |
| Net Income | -2.5 Million | -2.01 Million | -1.02 Million | -2.96 Million | -3.33 Million | -14.64 Million |
| Earnings Per Share Basic | -0.95 | -0.92 | -0.47 | -1.72 | -1.97 | - |
| Earnings Per Share Diluted | -0.95 | -0.45 | -0.24 | -1.72 | -1.96 | - |
| Weighted Average Shares Outstanding | 2.63 Million | 4.45 Million | 4.33 Million | 1.71 Million | 1.69 Million | 1.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.63 Million | 4.45 Million | 4.33 Million | 1.71 Million | 1.69 Million | 1.62 Million |
| Gross Margin | 0.50 | - | - | - | - | - |
| EBIT Margin | -33.09 | - | - | - | - | - |
| Profit Margin | -32.96 | - | - | - | - | - |
| EBITDA | -2.51 Million | -2.07 Million | -1 Million | -2.94 Million | -3.33 Million | - |
| Earnings Before Tax Margin | 82.12 | - | - | - | - | - |
0I8W
BIOE
ANI
JETFREIGHT
009180
ARET